|
KMID : 0985520160210020101
|
|
Korean Journal of Pancreas and Biliary Tract
2016 Volume.21 No. 2 p.101 ~ p.106
|
|
|
A Case of Curative Resection of Advanced Combined Hepatocellular-cholangiocarcinoma after Neoadjuvant Chemotherapy
|
|
최지은:Choi Jee-Eun
김경희:Kim Kyung-Hee/김선아:Kim Seon-A/이정환:Lee Jung-Hwan/우상명:Woo Sang-Myung/박상재:Park Sang-Jae/홍은경:Hong Eun-Kyung/이우진:Lee Woo-Jin
|
|
|
Abstract
|
|
|
|
Combined hepatocellular-cholangiocarcinoma (HCC-CC) is a primary liver cancer with histopathologic features of both hepatocelluar carcinoma and cholangiocarcinoma. As combined HCC-CC has been associated with poor outcomes, accurate diagnosis and proper treatment planning for patients are considered to be important for improving survival. Currently, surgery is known as the only treatment modality offering potential cure for localized disease. However, there are little published treatment options for advanced or recurrent disease. Furthermore, no published reports exist in respect to the applying successful curative resection after neoadjuvant therapy for advanced combined HCC-CC. Here, we report a case of combined HCC-CC subtype with stem cell feature, intermediate type who underwent curative surgical resection after neoadjuvant chemotherapy consisting of cisplatin and gemcitabine. Pathologic report revealed negative resection margin and follow-up imaging study shows no evidence of tumor recurrence.
|
|
|
KEYWORD
|
|
|
Combined hepatocellular-cholangiocarcinoma, Neoadjuvant chemotherapy, Curative resection
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|
|